Exagen Inc.
General ticker "XGN" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $134.7M (TTM average)
Exagen Inc. follows the US Stock Market performance with the rate: 45.9%.
Estimated limits based on current volatility of 7.0%: low 4.67$, high 5.38$
Factors to consider:
- Total employees count: 209 (+16.8%) as of 2024
- Top business risk factors: Third-party risks, Single supplier dependency, Labor/talent shortage/retention, Strategic risks and growth management, Market acceptance
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.70$, 6.64$]
- 2025-12-31 to 2026-12-31 estimated range: [2.05$, 5.12$]
Financial Metrics affecting the XGN estimates:
- Positive: with PPE of -5.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.10 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: 19.35 < Shareholder equity ratio, % of 21.35 <= 42.53
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
- Negative: negative Net income
Short-term XGN quotes
Long-term XGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $45.56MM | $52.55MM | $55.64MM |
| Operating Expenses | $91.61MM | $75.39MM | $69.28MM |
| Operating Income | $-46.05MM | $-22.84MM | $-13.64MM |
| Non-Operating Income | $-1.62MM | $-0.82MM | $-1.47MM |
| Interest Expense | $2.45MM | $2.33MM | $2.23MM |
| R&D Expense | $9.88MM | $4.87MM | $5.38MM |
| Income(Loss) | $-47.67MM | $-23.66MM | $-15.10MM |
| Taxes | $-0.28MM | $0.03MM | $0.01MM |
| Profit(Loss)* | $-47.39MM | $-23.69MM | $-15.12MM |
| Stockholders Equity | $42.46MM | $22.69MM | $9.54MM |
| Assets | $86.22MM | $56.94MM | $44.69MM |
| Operating Cash Flow | $-32.14MM | $-14.46MM | $-13.28MM |
| Capital expenditure | $4.32MM | $0.83MM | $0.52MM |
| Investing Cash Flow | $-4.32MM | $-0.80MM | $-0.52MM |
| Financing Cash Flow | $-0.49MM | $-10.63MM | $-0.66MM |
| Earnings Per Share** | $-2.77 | $-1.34 | $-0.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.